Did you miss any of September's pivotal @fda.gov oncology approvals? Catch up here with the data and significance of each decision #bcsm #lcsm #oncology

Read more: www.onclive.com/view/septemb...

🚨 BREAKING 🚨: The @fda.gov approved maintenance tucatinib plus trastuzumab and pertuzumab for unresectable locally advanced or metastatic HER2-positive breast cancer following induction treatment. #bcsm #oncology

Full story ➡️: www.onclive.com/view/fda-app...

WATCH 🎥: Alexis Ann LeVee, MD, previews the lidERA Breast Cancer PRO data being presented at the 2026 ESMO Congress. @myesmo.bsky.social #ESMO2026 #bcsm #oncology

Sign up to read the full preview ➡️: www.onclive.com/view/breast-...

WATCH 🎥: @kalinskykevin.bsky.social, of @winshipcancer.emory.edu, discusses key breast cancer abstracts being presented at the 2026 ESMO Congress. @myesmo.bsky.social #ESMO2026 #bcsm #oncology

Sign up to read our preview article for more insights ➡️: www.onclive.com/view/breast-...

Last week's #OncFive:

✅ Pirtobrutinib OK'd in 1L CLL/SLL #lymsm #leusm
🎗️ Priority review: elinzanetant for breast cancer #bcsm
🩸 Tabelecleucel BLA resubmitted in EBV+ PTLD
🫁 Savolitinib+osimertinib NDA in MET+ NSCLC #lcsm
🫁 Zipalertinib NDA starts in NSCLC

🔗: www.onclive.com/view/the-onc...

Five facts explain why male #breastcancer happens and what changes its outcome. They involve where the first sign shows up, how the disease runs in families, what raises risk and why treatment still borrows from research on women.

#nenshealth #bcsm #hereditarycancer #BRCA

Did you miss key updates in NSCLC, breast cancer, MDS, and PTLD? Test your knowledge with this week's OncLive news quiz #lcsm #bcsm #mpnsm #oncology

www.onclive.com/view/onclive...

lobularbreastcancer.org/lbca-research-grantee-interview-exploring-what-drives-ilc-metastasis/ #bcsm, #lobularbreastcan #ILC, #lobular, #ILCAwareness, #learnaboutlobular
Christina Curtis & Deborah Rohmer: Important new ILC research and "how to's of good advocacy".

If you saw the study saying GLP1s have an outlandish effect on breast cancer survival and recurrence based on electronic medical records, and were underwhelmed, this study took a different approach, addressing prevention 🧪 CanSky OncoSky #breastcancer #BCSM #ThinkPink #KnowYourRisk

Breast cancer Tx can have lasting effects on CV health, making heart care essential to survivorship. This #BreastCancerAwarenessMonth, explore how #JACCCardioOnc advances cancer & CV care through research, expert perspectives & clinical insights. https://bit.ly/3ThPZmG #BreastCancerAwareness #BCsm

👀 Looking ahead to the 2026 ESMO Congress? See which breast cancer presentations @kalinskykevin.bsky.social, of @winshipcancer.emory.edu, and Alexis Ann LeVee, MD, are most looking forward to. @myesmo.bsky.social #bcsm #oncology

Sign up to read the full preview ➡️: www.onclive.com/view/breast-...

🧬 Researchers at @wakeforestmed.bsky.social identified a protein that may help breast cancer spread to the brain and evade immune defenses. #bcsm #oncology

Read more ➡️: www.onclive.com/view/researc...

📰 The @fda.gov has granted priority review to elinzanetant for the treatment of moderate-to-severe vasomotor symptoms in patients receiving endocrine therapy for the management or prevention of HR+ breast cancer. #bcsm #oncology

Read more ➡️: www.onclive.com/view/fda-gra...

Dr. Karen van Baelen looked at modifiable risk factors in #ILC recurrence. Physical activity once again shown to be beneficial for #breastcancer patients! #ILCSymposium #lobmob #bcsm #exerciseismedicine

Guilford breaks down clinical management of hereditary diffuse #gastriccancer which is intense. Patients often have their stomachs removed, which comes w/ many adverse effects (& a few bennies, he noted, tongue firmly in cheek). #ILCSymposium #HDGC #lobmob #bcsm

Guilford proposes using the term hereditary diffuse gastric & #lobular #breastcancer syndrome for those w/ #CDH1 mutation since many people who survive #gastric #cancer will develop #lobularBC. #ILCSymposium @lobularbca.bsky.social @elbcc-2018.bsky.social #bcsm #lobmob

Keynote speaker Dr. Parry Guilford breaks down the similarities between #lobular #breastcancer and diffuse #gastriccancer via a hereditary #CDH1 mutation. #ILCSymposium. Good to know as we enter Hereditary Cancer Awareness Week! #bcsm @lobularbca.bsky.social

There's been "tremendous progress" in the creation of scientific models of #ILC for research -- always good for patients to hear! And more coming, per Dr. Adrien Lee. #ILCSymposium #BCSM @lobularbca.bsky.social @elbcc-2018.bsky.social @lobularbcuk.bsky.social

#Cancer researchers' favorite font, Comic Sans, rears its head at the #ILCSymposium. 😉 #CanSky #BCSM #funwithfonts

First up this morning, @fredhutch.org's translational researcher Dr. Kevin Cheung talking about the #metastatic "interactome" in #lobular #breastcancer #CanSky #ILCSymposium #bcsm @lobularbca.bsky.social @elbcc-2018.bsky.social @lobularbcuk.bsky.social